Theriva™ Biologics Announces Presentation Describing Next Generation Oncolytic Adenovirus ... 05/11/2025 Healthcare Preclinical data for VCN-12, the next candidate from Theriva’s VCN-X discovery program, highlight a novel mechanism of... Partners - THERIVA BIOLOGICS S.L.
Public research at the Barcelona Science Park – UB reaches a record investment of €84 mill... 04/11/2025 Healthcare The public research institutes, together with the units and groups of the University of Barcelona (UB) present at the... Partners - Parc Científic de Barcelona
ORYZON announces First‑Patient‑In (FPI) in RESTORE Phase Ib trial of iadademstat in sickle... 03/11/2025 Healthcare Recently approved by the European Medicines Agency, RESTORE will evaluate iadademstat’s ability to raise fetal... Partners - Oryzon Genomics
BCN HEALTH publica un estudio evaluando la incidencia y el coste de la enfermedad renal cr... 03/11/2025 Healthcare BCN HEALTH has published in the Journal of Medical Economics a study analyzing the incidence, management, and associated... Partners - BCN Health
Natac records revenues of €31.88 million through mid-October 04/11/2025 Healthcare The company expects to close the year with sales exceeding €50 million and an EBITDA above €20 million Partners - Natac Group
Glycobasque 8 brought together leading international figures in glycosciences in San Sebas... 29/10/2025 Healthcare The eighth edition of Glycobasque turned San Sebastián into a hub for glycoscience research on October 23–24. The... Partners - ASPARIA GLYCOMICS
Innovation, research, and the future: biotechnology sets the course for psoriasis treatmen... 29/10/2025 Inhibitec Anticuerpos Biotechnology enables the development of more effective and personalized treatments for chronic inflammatory diseases... AseBio - Inhibitec Anticuerpos
When biotechnology puts itself in the patient’s skin 29/10/2025 Healthcare Access to innovation Innovative drugs The biotech company Inhibitec is advancing the development of an antibody targeting the BAMBI molecule, with therapeutic... AseBio - Inhibitec Anticuerpos
Biotechnology: a key ally in the fight against breast cancer 19/10/2025 Healthcare Access to innovation According to the AECC, around 35,875 new cases were diagnosed in 2024, accounting for nearly 29% of all tumors detected... AseBio - InnoUp Farma
Biotechnology: a key ally in the fight against breast cancer 19/10/2025 InnoUp Farma Biotechnological innovation is transforming treatments toward safer, more effective and personalized options... AseBio - InnoUp Farma
